NASDAQ:IMUX - Immunic News Headlines

$13.55
+0.41 (+3.12 %)
(As of 07/22/2019 09:06 AM ET)
Today's Range
$13.10
Now: $13.55
$13.8358
50-Day Range N/A
52-Week Range
$6.00
Now: $13.55
$390.00
Volume63,773 shs
Average Volume391,003 shs
Market Capitalization$14.36 million
P/E RatioN/A
Dividend YieldN/A
Beta3.69

Headlines

Immunic (NASDAQ IMUX) News Headlines

Source:
DateHeadline
Could Immunic, Inc.'s (NASDAQ:IMUX) Investor Composition Influence The Stock Price?Could Immunic, Inc.'s (NASDAQ:IMUX) Investor Composition Influence The Stock Price?
finance.yahoo.com - July 19 at 3:15 PM
Immunic, Inc. (IMUX)Immunic, Inc. (IMUX)
seekingalpha.com - July 18 at 5:08 AM
Immunic -3.5% after filing to offer $40M in stockImmunic -3.5% after filing to offer $40M in stock
seekingalpha.com - July 18 at 5:08 AM
New financial chief at ImmunicNew financial chief at Immunic
seekingalpha.com - July 17 at 9:23 AM
Immunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial OfficerImmunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial Officer
finance.yahoo.com - July 17 at 9:23 AM
Immunic, Inc. to Participate in Upcoming May ConferencesImmunic, Inc. to Participate in Upcoming May Conferences
finance.yahoo.com - July 17 at 9:23 AM
Immunic, Inc. to Participate in Investor and Scientific Conferences in JuneImmunic, Inc. to Participate in Investor and Scientific Conferences in June
finance.yahoo.com - July 17 at 9:23 AM
Immunic, Inc. to Present Newly Available Preclinical Data for IMU-935 in Poster Presentation at the 2ⁿᵈ Conference on Molecular Mechanisms of Inflammation in Trondheim, NorwayImmunic, Inc. to Present Newly Available Preclinical Data for IMU-935 in Poster Presentation at the 2ⁿᵈ Conference on Molecular Mechanisms of Inflammation in Trondheim, Norway
finance.yahoo.com - July 17 at 9:23 AM
Immunic, Inc. Files Financial Statements and Pro Forma Financial Information in Accordance with Previously Completed Stock-for-Stock Exchange Transaction and Provides Corporate UpdateImmunic, Inc. Files Financial Statements and Pro Forma Financial Information in Accordance with Previously Completed Stock-for-Stock Exchange Transaction and Provides Corporate Update
finance.yahoo.com - July 17 at 9:23 AM
Immunic, Inc. to Present Previously Unpublished Data Regarding Lead Program, IMU-838, at the GI Inflammatory Diseases Summit in BostonImmunic, Inc. to Present Previously Unpublished Data Regarding Lead Program, IMU-838, at the GI Inflammatory Diseases Summit in Boston
finance.yahoo.com - July 17 at 9:23 AM
Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial OfficerImmunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer
finance.yahoo.com - July 17 at 9:23 AM
Short Interest in Immunic (NASDAQ:IMUX) Grows By 8.1%Short Interest in Immunic (NASDAQ:IMUX) Grows By 8.1%
www.americanbankingnews.com - July 15 at 1:37 AM
 Immunic (NASDAQ:IMUX) Given $50.00 Average Target Price by Brokerages Immunic (NASDAQ:IMUX) Given $50.00 Average Target Price by Brokerages
www.americanbankingnews.com - July 11 at 4:25 PM
Immunic (NASDAQ:IMUX) Coverage Initiated by Analysts at Chardan CapitalImmunic (NASDAQ:IMUX) Coverage Initiated by Analysts at Chardan Capital
www.americanbankingnews.com - July 11 at 12:19 PM
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel